CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 62.5%

Compliant submissions 5

Incompliant submissions 3

Total trials 8

My Organizations' Clinical Trials

Showing 225 of 1349 entries

View as:

Effects of Low and Moderate Fat Diets on Lipids, Inflammation and Vascular Reactivity in the Metabolic Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT00362908 Org: User:

Start: 09/30/06 End: 06/30/10 Due: 06/30/11

Triglyceride Effects on Blood Flow in the Human Brain

Phase: N/A Priority: Normal

NCT ID: NCT05218018 Org: User:

Start: 03/01/20 End: 01/13/22 Due: 01/13/23

Multi-tasking to Hyper-tasking: Investigating the Impact of Next Generation 911

Phase: N/A Priority: Normal

NCT ID: NCT02961621 Org: User:

Start: 05/01/15 End: 12/15/17 Due: 12/15/18

Novel Immune Markers in Patients With Multiple Sclerosis

Phase: N/A Priority: Normal

NCT ID: NCT01026272 Org: User:

Start: 01/31/10 End: 05/31/11 Due: 05/31/12

Infant TB Infection Prevention Study

Phase: N/A Priority: Normal

NCT ID: NCT02613169 Org: User:

Start: 08/31/16 End: 12/31/20 Due: 12/31/21

Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial

Phase: N/A Priority: Normal

NCT ID: NCT05161533 Org: User:

Start: 10/19/23 End: 12/31/24 Due: 12/31/25

Mobile Health Intervention to Support Healthful Diet

Phase: N/A Priority: Normal

NCT ID: NCT05236712 Org: User:

Start: 01/01/22 End: 02/28/23 Due: 02/28/24

Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease

Phase: N/A Priority: Normal

NCT ID: NCT00552409 Org: User:

Start: 12/31/07 End: 06/30/10 Due: 06/30/11

Dietary Treatment of Hyperlipidemia in Women vs. Men

Phase: N/A Priority: Normal

NCT ID: NCT00005336 Org: User:

Start: 04/30/91 End: 09/30/96 Due: 09/30/97

Effectiveness of Frontal Plane Adaptability in a Novel Foot Prosthesis

Phase: N/A Priority: Normal

NCT ID: NCT06214026 Org: User:

Start: 09/01/23 End: 04/30/27 Due: 04/30/28

Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer

Phase: N/A Priority: Normal

NCT ID: NCT01731912 Org: User:

Start: 05/31/13 End: 09/30/16 Due: 09/30/17

Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery

Phase: N/A Priority: Normal

NCT ID: NCT00407888 Org: User:

Start: 05/31/06 End: 07/31/12 Due: 07/31/13

Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV

Phase: N/A Priority: Normal

NCT ID: NCT01433185 Org: User:

Start: 04/30/12 End: 07/31/13 Due: 07/31/14

Magnesium Sulfate For Brain Injury

Phase: N/A Priority: Normal

NCT ID: NCT00004730 Org: User:

Start: 08/31/98 End: 05/31/05 Due: 05/31/06

Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2

Phase: N/A Priority: Normal

NCT ID: NCT00363012 Org: User:

Start: 04/30/06 End: 03/31/10 Due: 03/31/11

Stroke and CPAP Outcome Study 3

Phase: N/A Priority: Normal

NCT ID: NCT06029959 Org: User:

Start: 10/01/23 End: 01/01/25 Due: 01/01/26

Cardiovascular Effects of Racemic Epinephrine Pellets

Phase: N/A Priority: Normal

NCT ID: NCT04688346 Org: User:

Start: 06/10/19 End: 11/30/19 Due: 11/30/20

Mutations, Hormone Therapy (HRT) and Venous Thromboembolism

Phase: N/A Priority: Normal

NCT ID: NCT00005515 Org: User:

Start: 09/30/98 End: 08/31/03 Due: 08/31/04

Real-Time Support for Exercise Persistence in COPD

Phase: N/A Priority: Normal

NCT ID: NCT00373932 Org: User:

Start: 05/31/06 End: 12/31/08 Due: 12/31/09

Loncastuximab Tesirine for the Treatment of Relapsed or Refractory B-Cell Malignancies

Phase: N/A Priority: Normal

NCT ID: NCT05453396 Org: User:

Start: 08/07/23 End: 07/06/27 Due: 07/06/28

Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression

Phase: N/A Priority: Normal

NCT ID: NCT00507221 Org: User:

Start: 02/29/08 End: 10/31/11 Due: 10/31/12

The Role of GLP-1 in Satiety Perception in Humans

Phase: N/A Priority: Normal

NCT ID: NCT01152333 Org: User:

Start: 07/31/10 End: 07/31/16 Due: 07/31/17

The Emergency Department Longitudinal Integrated Care

Phase: N/A Priority: Normal

NCT ID: NCT05327166 Org: User:

Start: 04/12/22 End: 12/31/26 Due: 12/31/27

Skills for Talking About Cannabis for Families of Young Adults With Psychosis

Phase: N/A Priority: Normal

NCT ID: NCT06961877 Org: User:

Start: 07/31/25 End: 07/31/27 Due: 07/31/28

Managing Inflammatory Bowel Disease

Phase: N/A Priority: Normal

NCT ID: NCT00679003 Org: User:

Start: 09/30/07 End: 03/31/14 Due: 03/31/15

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Effects of Low and Moderate Fat Diets on Lipids, Inflammation and Vascular Reactivity in the Metabolic Syndrome	NCT00362908	University of Washington	user2@example.com	None	2006-09-30	2010-06-30	2011-06-30	-	-	2025-07-14
Triglyceride Effects on Blood Flow in the Human Brain	NCT05218018	University of Washington	user2@example.com	None	2020-03-01	2022-01-13	2023-01-13	-	-	2025-07-14
Multi-tasking to Hyper-tasking: Investigating the Impact of Next Generation 911	NCT02961621	University of Washington	user2@example.com	None	2015-05-01	2017-12-15	2018-12-15	-	-	2025-07-14
Novel Immune Markers in Patients With Multiple Sclerosis	NCT01026272	University of Washington	user2@example.com	None	2010-01-31	2011-05-31	2012-05-31	-	-	2025-07-14
Infant TB Infection Prevention Study	NCT02613169	University of Washington	user2@example.com	None	2016-08-31	2020-12-31	2021-12-31	-	-	2025-07-14
Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial	NCT05161533	University of Washington	user2@example.com	None	2023-10-19	2024-12-31	2025-12-31	-	-	2025-07-14
Mobile Health Intervention to Support Healthful Diet	NCT05236712	University of Washington	user2@example.com	None	2022-01-01	2023-02-28	2024-02-28	-	-	2025-07-14
Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease	NCT00552409	University of Washington	user2@example.com	None	2007-12-31	2010-06-30	2011-06-30	-	-	2025-07-14
Dietary Treatment of Hyperlipidemia in Women vs. Men	NCT00005336	University of Washington	user2@example.com	None	1991-04-30	1996-09-30	1997-09-30	-	-	2025-07-14
Effectiveness of Frontal Plane Adaptability in a Novel Foot Prosthesis	NCT06214026	University of Washington	user2@example.com	None	2023-09-01	2027-04-30	2028-04-30	-	-	2025-07-14
Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer	NCT01731912	University of Washington	user2@example.com	None	2013-05-31	2016-09-30	2017-09-30	-	-	2025-07-14
Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery	NCT00407888	University of Washington	user2@example.com	None	2006-05-31	2012-07-31	2013-07-31	-	-	2025-07-14
Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV	NCT01433185	University of Washington	user2@example.com	None	2012-04-30	2013-07-31	2014-07-31	-	-	2025-07-14
Magnesium Sulfate For Brain Injury	NCT00004730	University of Washington	user2@example.com	None	1998-08-31	2005-05-31	2006-05-31	-	-	2025-07-14
Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2	NCT00363012	University of Washington	user2@example.com	None	2006-04-30	2010-03-31	2011-03-31	-	-	2025-07-14
Stroke and CPAP Outcome Study 3	NCT06029959	University of Washington	user2@example.com	None	2023-10-01	2025-01-01	2026-01-01	-	-	2025-07-14
Cardiovascular Effects of Racemic Epinephrine Pellets	NCT04688346	University of Washington	user2@example.com	None	2019-06-10	2019-11-30	2020-11-30	-	-	2025-07-14
Mutations, Hormone Therapy (HRT) and Venous Thromboembolism	NCT00005515	University of Washington	user2@example.com	None	1998-09-30	2003-08-31	2004-08-31	-	-	2025-07-14
Real-Time Support for Exercise Persistence in COPD	NCT00373932	University of Washington	user2@example.com	None	2006-05-31	2008-12-31	2009-12-31	-	-	2025-07-14
Loncastuximab Tesirine for the Treatment of Relapsed or Refractory B-Cell Malignancies	NCT05453396	University of Washington	user2@example.com	None	2023-08-07	2027-07-06	2028-07-06	-	-	2025-07-14
Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression	NCT00507221	University of Washington	user2@example.com	None	2008-02-29	2011-10-31	2012-10-31	-	-	2025-07-14
The Role of GLP-1 in Satiety Perception in Humans	NCT01152333	University of Washington	user2@example.com	None	2010-07-31	2016-07-31	2017-07-31	-	-	2025-07-14
The Emergency Department Longitudinal Integrated Care	NCT05327166	University of Washington	user2@example.com	None	2022-04-12	2026-12-31	2027-12-31	-	-	2025-07-14
Skills for Talking About Cannabis for Families of Young Adults With Psychosis	NCT06961877	University of Washington	user2@example.com	None	2025-07-31	2027-07-31	2028-07-31	-	-	2025-07-14
Managing Inflammatory Bowel Disease	NCT00679003	University of Washington	user2@example.com	None	2007-09-30	2014-03-31	2015-03-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance